Francesca Novara

Francesca Novara

Auto-generated profile, based on publicly available information

Francesca Novara

Department of Molecular Medicine, University of Pavia, Pavia, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Cancer Research
Verified
Journal Article
Open access
PDF file
MBMaria Ester Bernardo
Maria Ester Bernardo
Nadia ZaffaroniNadia Zaffaroni
Nadia Zaffaroni
FNFrancesca Novara
Francesca Novara
ACAngela Maria Cometa
Angela Maria Cometa
SCStefania Croce
Stefania Croce
FLFranco Locatelli
Franco Locatelli
Significant improvement in the understanding of mesenchymal stem cell (MSC) biology has opened the way to their clinical use. However, concerns regarding the possibility that MSCs undergo malignant transformation have been raised. We investigated the susceptibility to transformation of human bone marrow (BM)–derived MSCs at different in vitro culture time points. MSCs were isolated from BM of 10 healthy donors and propagated in vitro until reaching either senescence or passage (P) 25. MSCs in the senescence phase were closely monitored for 8 to 12 weeks before interrupting the cultures. The genetic characterization of MSCs was investigated through array-comparative genomic hybridization (array-CGH), conventional karyotyping, and subtelomeric fluorescent in situ hybridization analysis both before and after prolonged culture. MSCs were tested for the expression of telomerase activity, human telomerase reverse transcriptase (hTERT) transcripts, and alternative lengthening of telomere (ALT) mechanism at different passages. A huge variability in terms of proliferative capacity and MSCs life span was noted between donors. In eight of 10 donors, MSCs displayed a progressive decrease in proliferative capacity until reaching senescence. In the remaining two MSC samples, the cultures were interrupted at P25 to pursue data analysis. Array-CGH and cytogenetic analyses showed that MSCs expanded in vitro did not show chromosomal abnormalities. Telomerase activity and hTERT transcripts were not expressed in any of the examined cultures and telomeres shortened during the culture period. ALT was not evidenced in the MSCs tested. BM-derived MSCs can be safely expanded in vitro and are not susceptible to malignant transformation, thus rendering these cells suitable for cell therapy approaches. [Cancer Res 2007;67(19):9142–9]

17 February 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ASAndrew J Sharp
Andrew J Sharp
HMHeather C Mefford
Heather C Mefford
KLKelly Li
Kelly Li
CBCarl Baker
Carl Baker
CSCindy Skinner
Cindy Skinner
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa

31 August 2007 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MGM De Gregori
M De Gregori
RCR Ciccone
R Ciccone
PMP Magini
P Magini
TPT Pramparo
T Pramparo
SGS Gimelli
S Gimelli
OZorsetta zuffardi
orsetta zuffardi
Using array comparative genome hybridisation (CGH) 41 de novo reciprocal translocations and 18 de novo complex chromosome rearrangements (CCRs) were screened. All cases had been interpreted as “balanced” by conventional cytogenetics. In all, 27 cases of reciprocal translocations were detected in patients with an abnormal phenotype, and after array CGH analysis, 11 were found to be unbalanced. Thus 40% (11 of 27) of patients with a “chromosomal phenotype” and an apparently balanced translocation were in fact unbalanced, and 18% (5 of 27) of the reciprocal translocations were instead complex rearrangements with >3 breakpoints. Fourteen fetuses with de novo, apparently balanced translocations, all but two with normal ultrasound findings, were also analysed and all were found to be normal using array CGH. Thirteen CCRs were detected in patients with abnormal phenotypes, two in women who had experienced repeated spontaneous abortions and three in fetuses. Sixteen patients were found to have unbalanced mutations, with up to 4 deletions. These results suggest that genome-wide array CGH may be advisable in all carriers of “balanced” CCRs. The parental origin of the deletions was investigated in 5 reciprocal translocations and 11 CCRs; all were found to be paternal. Using customised platforms in seven cases of CCRs, the deletion breakpoints were narrowed down to regions of a few hundred base pairs in length. No susceptibility motifs were associated with the imbalances. These results show that the phenotypic abnormalities of apparently balanced de novo CCRs are mainly due to cryptic deletions and that spermatogenesis is more prone to generate multiple chaotic chromosome imbalances and reciprocal translocations than oogenesis.

22 December 2006 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MBM.E. Bernardo
M.E. Bernardo
SCStefania Croce
Stefania Croce
CPCesare Perotti
Cesare Perotti
ACA.M. Cometa
A.M. Cometa
AMA. Moretta
A. Moretta
FLF. Locatelli
F. Locatelli

1 April 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Daniele GhezziDaniele Ghezzi
Daniele Ghezzi
ISIrina Sevrioukova
Irina Sevrioukova
FIFederica Invernizzi
Federica Invernizzi
CLCostanza Lamperti
Costanza Lamperti
MMMarina Mora
Marina Mora
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

14 July 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MBMaria Clara Bonaglia
Maria Clara Bonaglia
RGRoberto Giorda
Roberto Giorda
SBSilvana Beri
Silvana Beri
CACristina De Agostini
Cristina De Agostini
FNFrancesca Novara
Francesca Novara
OZorsetta zuffardi
orsetta zuffardi
In this study, we used deletions at 22q13, which represent a substantial source of human pathology (Phelan/McDermid syndrome), as a model for investigating the molecular mechanisms of terminal deletions that are currently poorly understood. We characterized at the molecular level the genomic rearrangement in 44 unrelated patients with 22q13 monosomy resulting from simple terminal deletions (72%), ring chromosomes (14%), and unbalanced translocations (7%). We also discovered interstitial deletions between 17–74 kb in 9% of the patients. Haploinsufficiency of the SHANK3 gene, confirmed in all rearrangements, is very likely the cause of the major neurological features associated with PMS. SHANK3 mutations can also result in language and/or social interaction disabilities. We determined the breakpoint junctions in 29 cases, providing a realistic snapshot of the variety of mechanisms driving non-recurrent deletion and repair at chromosome ends. De novo telomere synthesis and telomere capture are used to repair terminal deletions; non-homologous end-joining or microhomology-mediated break-induced replication is probably involved in ring 22 formation and translocations; non-homologous end-joining and fork stalling and template switching prevail in cases with interstitial 22q13.3. For the first time, we also demonstrated that distinct stabilizing events of the same terminal deletion can occur in different early embryonic cells, proving that terminal deletions can be repaired by multistep healing events and supporting the recent hypothesis that rare pathogenic germline rearrangements may have mitotic origin. Finally, the progressive clinical deterioration observed throughout the longitudinal medical history of three subjects over forty years supports the hypothesis of a role for SHANK3 haploinsufficiency in neurological deterioration, in addition to its involvement in the neurobehavioral phenotype of PMS. Terminal chromosome deletions are among the most commonly observed rearrangements detected by cytogenetics and may result in several well-known genetic syndromes. We used 22q13 deletions to study how these types of chromosome abnormalities arise. Children with Phelan/McDermid syndrome, caused by deletion of the terminal portion of chromosome 22, experience developmental delay, absent or severely delayed speech, and frequent behavioral problems. Lack of one copy of SHANK3, a key gene for the correct development and organization of brain synapses, is very likely the basis of the syndrome's major neurological features. Deletion of additional genes probably causes more complex phenotypes in subjects with larger deletions. We also studied patients who only lack a portion of SHANK3 and demonstrated that small, hard-to-detect deletions of this gene may cause substantial clinical problems. Until now, the 22q distal deletion had been only diagnosed in very young people. We studied a large group of patients of different ages and discovered that all adult patients face progressive cognitive decline. Our study demonstrates that deletion of the terminal portion of chromosome 22, a prototype for terminal deletions in human chromosomes, can occur in several ways. Mosaic deletions of different size can also form in early embryogenesis.